Activity of Cefiderocol and Comparators against Isolates from Cancer Patients

被引：49
|
作者：
Rolston, Kenneth V. I. [1 ]
Gerges, Baghat [1 ]
Shelburne, Samuel [1 ]
Aitken, Samuel L. [2 ]
Raad, Issam [1 ]
Prince, Randall A. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Div Pharm, Houston, TX 77030 USA
来源：
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY | 2020年 / 64卷 / 05期
关键词：
Gram-negative isolates; Pseudomonas aeruginosa; Stenotrophomonas maltophilia; cefiderocol; VITRO ANTIMICROBIAL ACTIVITY; SIDEROPHORE CEPHALOSPORIN; S-649266;
D O I：
10.1128/AAC.01955-19
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at <= 4 mg/liter. It had potent activity against extended-spectrum beta-lactamase-positive Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE), and nonfermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter species isolates. Amikacin, ceftazidime-avibactam, and meropenem had appreciable activity against non-CRE Enterobacteriaceae. No comparators were active against multidrug-resistant P. aeruginosa isolates. Only trimethoprim-sulfamethoxazole had appreciable activity against S. maltophilia isolates. Overall, cefiderocol was associated with the lowest level of resistance.
引用
收藏
页数：7
相关论文
共 50 条
  • [41] In vitro activity of imipenem/releactam and comparator agents against clinical bacterial isolates from patients with cancer
    Rolston, Kenneth V., I
    Gerges, Bahgat Z.
    Reitzel, Ruth
    Shelburne, Samuel A.
    Aitken, Samuel L.
    Raad, Issam I.
    Prince, Randall A.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2022, 29 : 1 - 6
  • [42] In vitro antimicrobial activity of gatifloxacin compared with other quinolones against clinical isolates from cancer patients
    Rolston, KVI
    Vaziri, I
    Frisbee-Hume, S
    Streeter, H
    LeBlanc, B
    CHEMOTHERAPY, 2004, 50 (05) : 214 - 220
  • [43] Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
    Zahra Taheri Rizi
    Mahdi Abastabar
    Hamed Fakhim
    Macit Ilkit
    Fatemeh Ahangarkani
    Javad Javidnia
    Iman Haghani
    Jacques F. Meis
    Hamid Badali
    Mycopathologia, 2020, 185 : 357 - 365
  • [44] Antifungal Activity of a Novel Triazole, Efinaconazole and Nine Comparators against 354 Molecularly Identified Aspergillus Isolates
    Taheri Rizi, Zahra
    Abastabar, Mahdi
    Fakhim, Hamed
    Ilkit, Macit
    Ahangarkani, Fatemeh
    Javidnia, Javad
    Haghani, Iman
    Meis, Jacques F.
    Badali, Hamid
    MYCOPATHOLOGIA, 2020, 185 (02) : 357 - 365
  • [45] In vitro activity of the newly approved antimicrobial agent Cefiderocol against Carbapenem resistant Gram negative clinical isolates
    Khanchandani, Himanshi
    Chaudhury, Madhulika
    Rao, M. Srihari
    Ramakrishna, N.
    Venkataramana, B.
    Chaudhury, Abhijit
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2024, 48
  • [46] In vitro activity of ceftolozane/tazobactam, ceftazidime/avibactam and cefiderocol against clinical isolates of non-aeruginosa Pseudomonas
    Thene, Lucie
    Floch, Pauline
    Chagneau, Camille, V
    Dubois, Damien
    Massip, Clemence
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2025,
  • [47] In vitro antibacterial activity of cefiderocol against recent multidrug-resistant carbapenem-nonsusceptible Enterobacterales isolates
    Zhang, Qingyu
    Neidig, Nicholas
    Chu, Ting-Yu
    Divoky, Cameron
    Carpenter, Jessica
    Lee-Hsiao, Cristian
    Threatt, Hillary
    Sultana, Rasheda
    Bush, Karen
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2022, 103 (01)
  • [48] In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience
    Quirino, Angela
    Cicino, Claudia
    Scaglione, Vincenzo
    Marascio, Nadia
    Serapide, Francesca
    Scarlata, Giuseppe Guido Maria
    Lionello, Rosaria
    Divenuto, Francesca
    La Gamba, Valentina
    Pavia, Grazia
    Russo, Alessandro
    Torti, Carlo
    Matera, Giovanni
    Trecarichi, Enrico Maria
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2023, 15 (01)
  • [49] In vitro activity of manogepix and comparators against infrequently encountered yeast and mold isolates from the SENTRY Surveillance Program (2017-2022)
    Pfaller, Michael
    Huband, Michael
    Bien, Paul A.
    Carvalhaes, Cecilia G.
    Klauer, Abby
    Castanheira, Mariana
    Krysan, Damian J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2024, 68 (02)
  • [50] In vitro activity of tigecycline and comparators against carbapenem-susceptible and resistant Acinetobacter baumannii clinical isolates in Italy
    Mezzatesta M.L.
    Trovato G.
    Gona F.
    Nicolosi V.M.
    Nicolosi D.
    Carattoli A.
    Fadda G.
    Nicoletti G.
    Stefani S.
    Annals of Clinical Microbiology and Antimicrobials, 7 (1)
12345